Monday, March 4, 2024 • 7:00–8:00 AM

Florida Ballroom 4 • Hilton Orlando • Orlando, Florida
Breakfast will be provided

Earn AMA PRA Category 1 Credit(s)™ • ANCC Nursing Contact Hours
AAPA Category 1 CME credits • ACPE Pharmacy Contact Hours

Why Attend?

Dive into the development of management techniques for patients with DMD and explore emerging therapies to slow disease progression. This symposium will focus on dystrophin disruption and restoration and highlight the most recent clinical trial results across treatment modalities. Expert faculty will conclude with a case-based discussion to sharpen learners’ skills for identifying the best management strategies for individual patients.

*MDA does not approve or endorse any commercial products or services discussed during the session or offered for sale by the organizer of the event.


Topics Featured in the Presentation:

  • Introduction to Dystrophin
  • Class of Therapies:
    • Exon Skipping Therapy
    • Gene Transfer Therapy
    • Small Molecule Therapy
    • Glucocorticoids
    • Immunotherapy
    • Cell-based Therapy
  • Case-based Discussion

Register to Attend



Craig McDonald, MD
Chair, Department of Physical Medicine & Rehabilitation
Professor, Departments of Pediatrics and Physical Medicine & Rehabilitation
UC Davis Health-Sacramento
Sacramento, CA


Crystal Proud, MD
Pediatric Neurologist
Children’s Hospital of The King’s Daughters
Norfolk, VA


Aravindhan Veerapandiyan, MD
Child Neurologist and Assistant Professor
University of Arkansas
Little Rock, AR

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

Chandler Building, 84 Lyme Street, Old Lyme, CT USA